Trends in glioblastoma treatment, survival, and disparities in access to care in the United States from 2004 to 2019: a National Cancer Database analysis
Improvements observed in OS for glioblastoma over the past 2 decades were associated with an increased use of trimodal therapy in accordance with clinical guidelines. Addressing ongoing disparities in the access to established and novel therapeutic modalities for glioblastoma is necessary to optimize outcomes and enhance research discoveries.
Authors
- Sean Lawler (ORCID: https://orcid.org/0000-0002-1633-2339)
- Frank J. Attenello (ORCID: https://orcid.org/0000-0002-7218-8669)
- David J. Coté (ORCID: https://orcid.org/0000-0001-5419-1517)
- Clark C. Chen (ORCID: https://orcid.org/0000-0001-9544-2570)
- John Pham (ORCID: https://orcid.org/0000-0003-2762-9047)
- Ishan Shah (ORCID: https://orcid.org/0000-0003-2249-1827)
- Robert G. Briggs (ORCID: https://orcid.org/0000-0001-9329-4471)
- Jonathan Sisti (ORCID: https://orcid.org/0000-0001-9011-1668)
- Gabriel Zada (ORCID: https://orcid.org/0000-0001-5821-902X)
- Keiko M. Kang
- David Gómez (ORCID: https://orcid.org/0000-0003-3612-661X)
Institutions
- University of Southern California (US)
- Brown University (US)
Publication Details
- Journal
- Journal of neurosurgery
- Published
- 2025-05-16
- DOI
- https://doi.org/10.3171/2025.1.jns242671
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00